IMI moves forward

Nature Biotechnology

Volumn 29, Issue 8, 2011, Pages 689-690

  Strohmeier, Rudolf ^a,b   Draghia Akli, Ruxandra ^a,b   Rys, Andrzej ^a,b   Silvan, Pedro Ortun ^a,b   Lennon, Theodius ^a,b   Incerti, Carlo ^b,c   Bergström, Richard ^b,c   Chibout, Salahdine ^b,c   Doliveux, Roch ^b,c   Andersen, Peter Hongaard ^b,c   Goldman, Michel ^b  

^a EUROPEAN COMMISSION   (Belgium)

^b Innovative Medicines Initiative (IMI)   (Belgium)

^c EFPIA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; LETTER; MEDICAL RESEARCH; MEDICAL SOCIETY; PATENT; POLICY; PRIORITY JOURNAL;

FINANCIAL SUPPORT; FINANCING, ORGANIZED; INTELLECTUAL PROPERTY; THERAPIES, INVESTIGATIONAL;

EID: 79961206318     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1944     Document Type: Letter

References (5)

1. Sinha, G. Nat. Biotechnol. 29, 473 (2011).
2. Editorial. Nat. Biotechnol. 29, 551 (2011).
3. Abbott, A. Nature 468, 158-159 (2010).
4. Matheis, K.J. et al. Drug Discov. Today (in press).
5. Obiol-Pardo, C., Gomis-Tena, J., Ferran Sanz, F., Saiz, F. & Pastor, M. J. Chem. Inf. Model. 51, 483-492 (2011).